Catalyst Biosciences to Present at Two Upcoming Healthcare Investor Conferences Sep 25, 2018 08:00AM
Catalyst Biosciences (CBIO) PT Lowered to $24.50 at Ladenburg Thalmann Jun 18, 2018 09:22AM
Catalyst Biosciences Announces Closing of Public Offering of Common Stock Feb 15, 2018 11:43AM
Catalyst Biosciences (CBIO) Prices 2.94M Shares at $34 Feb 13, 2018 08:47AM
Catalyst Biosciences Announces Pricing of Public Offering of Common Stock Feb 13, 2018 08:46AM


Feb 12, 2018 04:34PM Catalyst Biosciences (CBIO) to Offer Common Stock
Feb 12, 2018 04:33PM Catalyst Biosciences Announces Proposed Public Offering of Common Stock
Feb 9, 2018 06:53AM Catalyst Biosciences (CBIO) PT Raised to $47 at Ladenburg Thalmann; 'Compelling Hemophilia B Data, Longer Dosing Offers Upside'
Dec 22, 2017 12:15PM Catalyst Biosciences Announces Closing of Public Offering of Common Stock
Dec 20, 2017 09:15AM Catalyst Biosciences (CBIO) Prices 1.1M Share Common Offering at $9.50/Sh
Dec 20, 2017 09:11AM Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
Dec 19, 2017 04:51PM Catalyst Biosciences (CBIO) Plans Public Offering of Common Stock
Dec 19, 2017 04:51PM Catalyst Biosciences Announces Proposed Public Offering of Common Stock
Dec 18, 2017 10:02AM Catalyst Biosciences (CBIO) PT Raised to $14.25 at Ladenburg Thalmann, 'Accelerated Hemophilia B Clinical Timeline De-Risks Outlook'
Sep 22, 2017 08:01AM Catalyst Biosciences to Present at the Ladenburg Thalmann 2017 Healthcare Conference
Jun 6, 2017 09:39AM Pre-Open Movers 06/06: (NIHD) (EGLT) (GIII) Higher; (HDS) (FRAN) (CONN) Lower (more...)
Jun 6, 2017 06:58AM UPDATE: Ladenburg Thalmann Starts Catalyst Biosciences (CBIO) at Buy
Apr 12, 2017 04:01PM Catalyst Biosciences Announces Closing of a $20.7 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
Apr 7, 2017 08:40AM Catalyst Biosciences (CBIO) Prices Common Stock and Warrant Offering for Gross Proceeds of $18M
Apr 7, 2017 08:30AM Catalyst Biosciences Announces Pricing of $18 Million Underwritten Public Offering
Sep 23, 2016 08:00AM Catalyst Biosciences To Present at the Ladenburg Thalmann 2016 Healthcare Conference